EAST WINDSOR, N.J. — Aurobindo Pharma USA (Aurobindo) has proposed the acquisition of Lannett Co. (Lannett). The company says it anticipates closing the acquisition towards the middle of calendar 2026, subject to regulatory approval.
"Over the coming months, we will be providing additional updates on this exciting acquisition and how we expect it to enable us to better serve you, our valued customer," said Paul McMahon, president, APUSA Oral Solids Division at Aurobindo. "In the meantime, until the transaction closes, it will be business as usual in every respect with both Aurobindo and Lannett continuing to operate as separate entities. Please continue to work with your respective points of contact at Aurobindo and Lannett for any of your normal day-to-day business needs regarding the respective product portfolios, operational and transactional matters, etc," he added.
Aurobindo to purchase Lannett Co.
The company says it anticipates closing the acquisition towards the middle of calendar 2026, subject to regulatory approval.
Related
Gilead mobilizes rapid donation of remdesivir to support Ebola response
Building on decade-long commitment to outbreak relief.
On the menu at Grocers: Simple, sustainable changes to boost health
Benefits from high-fiber foods include lower cholesterol, more balanced blood sugar levels and improved energy levels.
Amneal announces full study population interim Phase 4 ELEVATE-PD results, reinforcing previously reported benefits of CREXONT in Parkinson's Disease
Phase 4 ELEVATE-PD interim data from the entire study population (n=214) continue to show clinically meaningful, consistent benefits of CREXONT across all prior treatment groups.
Latest
Sustainable pharmaceutical packaging market to top $270 billion by 2031
Pharmaceutical companies are increasing investments in sustainable packaging to meet environmental goals, regulations, and the demand for eco-friendly healthcare products.
Lioness, the first functional snack designed around the real moments of a woman's day, hits shelves at Target
Lioness functional snack brand built for the real moments of her day.
Ahold Delhaize USA to pay $40 million to settle drug pricing allegations
The Department of Justice announced the settlement. Claims are allegations only; no liability has been determined.
Camber launches generic Nimbex injection
The launch expands Camber’s hospital and acute care products and provides healthcare providers access to a widely used neuromuscular blocking agent for anesthesia and critical care.